Cdk5: one of the links between senile plaques and neurofibrillary tangles?

J Alzheimers Dis. 2003 Apr;5(2):127-37. doi: 10.3233/jad-2003-5207.


The relationship between amyloid plaques and neurofibrillary tangles, the two pathologic hallmarks of Alzheimer's disease (AD), is an unknown and controversial subject. However, emerging evidence from genetic and biochemical studies suggests that accumulation of amyloid beta peptides may play a causative role in AD pathogenesis. This led to the amyloid hypothesis, which proposes that amyloid beta peptides disrupt neuronal metabolic and ionic homeostasis and cause aberrant activation of kinases and/or inhibition of phosphatases. The resulting alteration in kinase and phosphatase activities ultimately leads to hyperphosphorylation of tau and formation of neurofibrillary tangles. Cyclin-dependent kinase 5 (Cdk5) is a tau kinase whose activity is induced by amyloid beta peptides. Its deregulation may represent one of the signal transduction pathways that connect amyloid beta toxicity to tau hyperphosphorylation. This article reviews the functions and regulation of Cdk5. Evidence that suggests deregulation of Cdk5 activity in AD by virtue of calpain cleavage of its activator p35 to p25 will be discussed.

Publication types

  • Review

MeSH terms

  • Alzheimer Disease / physiopathology*
  • Amyloid beta-Peptides / metabolism*
  • Amyloid beta-Protein Precursor / metabolism*
  • Cyclin-Dependent Kinase 5
  • Cyclin-Dependent Kinases / pharmacology*
  • Glycogen Synthase Kinase 3
  • Homeostasis
  • Humans
  • Neurofibrillary Tangles / pathology*
  • Plaque, Amyloid / enzymology*
  • Plaque, Amyloid / pathology*
  • Protein Serine-Threonine Kinases / pharmacology


  • Amyloid beta-Peptides
  • Amyloid beta-Protein Precursor
  • Cyclin-Dependent Kinase 5
  • Protein Serine-Threonine Kinases
  • CDK5 protein, human
  • Cyclin-Dependent Kinases
  • Glycogen Synthase Kinase 3
  • tau-protein kinase